Enhanced activity of superoxide dismutase is a common response to dietary and genetically induced increased cholesterol levels

References

• Puglielli L, Tanzi RE, Kovacs DM. Alzheimer's disease: the cholesterol connection. Nat Neurosci 2003;6(4):345–51.
   PubMed Web of Science ®Google Scholar
• Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 2003;61(2):199–205.
   PubMed Web of Science ®Google Scholar
• Martin MG, Pfrieger F, Dotti CG. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep 2014;15(10):1036–52.
   PubMed Web of Science ®Google Scholar
• Valenza M, Cattaneo E. Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list? Prog Neurobiol 2006;80(4):165–76.
   PubMed Web of Science ®Google Scholar
• Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology 2008;70(21):1972–9.
   PubMed Web of Science ®Google Scholar
• Paul R, Choudhury A, Borah A. Cholesterol – a putative endogenous contributor towards Parkinson's disease. Neurochem Int 2015;90:125–33.
   PubMed Web of Science ®Google Scholar
• Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322(7300):1447–51.
   PubMed Web of Science ®Google Scholar
• Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord 2009;28(1):75–80.
   PubMed Web of Science ®Google Scholar
• Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261(5123):921–3.
   PubMed Web of Science ®Google Scholar
• Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342(8873):697–9.
   PubMed Web of Science ®Google Scholar
• Fu R, Yanjanin NM, Elrick MJ, Ware C, Lieberman AP, Porter FD. Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1. Am J Med Genet A 2012: 158A(11):2775–80.
   PubMed Web of Science ®Google Scholar
• Williams-Gray CH, Goris A, Saiki M, Foltynie T, Compston DA, Sawcer SJ, et al. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease. J Neurol 2009;256(3):493–8.
   PubMed Web of Science ®Google Scholar
• Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011;10(3):241–52.
   PubMed Web of Science ®Google Scholar
• Panas M, Avramopoulos D, Karadima G, Petersen MB, Vassilopoulos D. Apolipoprotein E and presenilin-1 genotypes in Huntington's disease. J Neurol 1999;246(7):574–7.
   PubMed Web of Science ®Google Scholar
• Kalman J, Juhasz A, Majtenyi K, Rimanoczy A, Jakab K, Gardian G, et al. Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease. Neurobiol Aging 2000;21(4):555–8.
   PubMed Web of Science ®Google Scholar
• Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009;41(10):1088–93.
   PubMed Web of Science ®Google Scholar
• Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41(10):1094–9.
   PubMed Web of Science ®Google Scholar
• Wollmer MA. Cholesterol-related genes in Alzheimer's disease. Biochim Biophys Acta 2010;1801(8):762–73.
   PubMed Web of Science ®Google Scholar
• Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 1998;95(11):6460–4.
   PubMed Web of Science ®Google Scholar
• Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A 2001;98(10):5856–61.
   PubMed Web of Science ®Google Scholar
• Sparks DL, Scheff SW, Hunsaker JC3, Liu H, Landers T, Gross DR. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 1994;126(1):88–94.
   PubMed Web of Science ®Google Scholar
• Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000;7(4):321–31.
   PubMed Web of Science ®Google Scholar
• Wang C, Shou Y, Pan J, Du Y, Liu C, Wang H. The relationship between cholesterol level and Alzheimer's disease-associated APP proteolysis/Abeta metabolism. Nutr Neurosci 2018;21: 1–11.
   PubMedGoogle Scholar
• Riddell DR, Christie G, Hussain I, Dingwall C. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol 2001;11(16):1288–93.
   PubMed Web of Science ®Google Scholar
• Wahrle S, Das P, Nyborg AC, McLendon C, Shoji M, Kawarabayashi T, et al. Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis 2002;9(1):11–23.
   PubMed Web of Science ®Google Scholar
• Vetrivel KS, Thinakaran G. Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim Biophys Acta 2010;1801(8):860–7.
   PubMed Web of Science ®Google Scholar
• Oshima N, Morishima-Kawashima M, Yamaguchi H, Yoshimura M, Sugihara S, Khan K, et al. Accumulation of amyloid beta-protein in the low-density membrane domain accurately reflects the extent of beta-amyloid deposition in the brain. Am J Pathol 2001;158(6):2209–18.
   PubMed Web of Science ®Google Scholar
• Ehehalt R, Keller P, Haass C, Thiele C, Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003;160(1):113–23.
   PubMed Web of Science ®Google Scholar
• Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 2009;1793(4):664–73.
   PubMed Web of Science ®Google Scholar
• Schultz ML, Tecedor L, Chang M, Davidson BL. Clarifying lysosomal storage diseases. Trends Neurosci 2011;34(8):401–10.
   PubMed Web of Science ®Google Scholar
• Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, Futerman AH. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond. Mov Disord 2011;26(9):1593–604.
   PubMed Web of Science ®Google Scholar
• Westbroek W, Gustafson AM, Sidransky E. Exploring the link between glucocerebrosidase mutations and parkinsonism. Trends Mol Med 2011;17(9):485–93.
   PubMed Web of Science ®Google Scholar
• Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA, et al. Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011;146(1):37–52.
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Chang TY, Haass C, Ihara Y. Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells. J Biol Chem 2001;276(6):4454–60.
   PubMed Web of Science ®Google Scholar
• Saito Y, Suzuki K, Nanba E, Yamamoto T, Ohno K, Murayama S. Niemann-Pick type C disease: accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon 4 homozygosity. Ann Neurol 2002;52(3):351–5.
   PubMed Web of Science ®Google Scholar
• Jin LW, Shie FS, Maezawa I, Vincent I, Bird T. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am J Pathol 2004;164(3):975–85.
   PubMed Web of Science ®Google Scholar
• Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A 2004;101(7):2070–5.
   PubMed Web of Science ®Google Scholar
• Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L. Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis 2006;10(1):59–73.
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443(7113):787–795.
   PubMed Web of Science ®Google Scholar
• Saffari A, Kolker S, Hoffmann GF, Ebrahimi-Fakhari D. Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases. J Inherit Metab Dis 2017;40(5):631–40.
   PubMed Web of Science ®Google Scholar
• Torres S, Balboa E, Zanlungo S, Enrich C, Garcia-Ruiz C, Fernandez-Checa JC. Lysosomal and Mitochondrial Liaisons in Niemann-Pick Disease. Front Physiol 2017;8:982.
   PubMed Web of Science ®Google Scholar
• Schneiter R. Intracellular sterol transport in eukaryotes, a connection to mitochondrial function? Biochimie 2007;89(2):255–9.
   PubMed Web of Science ®Google Scholar
• Fernández A, Llacuna L, Fernández-Checa JC, Colell A. Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J Neurosci 2009;29(20):6394–405.
   PubMed Web of Science ®Google Scholar
• Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S, et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease. Science 2017;357(6357):1255–61.
   PubMed Web of Science ®Google Scholar
• Torres S, Matias N, Baulies A, Nuñez S, Alarcon-Vila C, Martinez L, et al. Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease. Redox Biol 2017;11:60–72.
   PubMed Web of Science ®Google Scholar
• Dominko K, Dikic D. Glutathionylation: a regulatory role of glutathione in physiological processes. Arh Hig Rada Toksikol 2018;69(1):1–24.
   PubMed Web of Science ®Google Scholar
• Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000;267(16):4904–11.
   PubMedGoogle Scholar
• Malnar M, Kosicek M, Lisica A, Posavec M, Krolo A, Njavro J, et al. Cholesterol-depletion corrects APP and BACE1 misstrafficking in NPC1-deficient cells. Biochim Biophys Acta 2012;1822(8):1270–83.
   PubMed Web of Science ®Google Scholar
• Jayakumar T, Thomas PA, Geraldine P. Protective effect of an extract of the oyster mushroom, Pleurotus ostreatus, on antioxidants of major organs of aged rats. Exp Gerontol 2007;42(3):183–91.
   PubMed Web of Science ®Google Scholar
• Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27(3):502–22.
   PubMed Web of Science ®Google Scholar
• Ngamchuea K, Batchelor-McAuley C, Compton RG. Rapid Method for the Quantification of Reduced and Oxidized Glutathione in Human Plasma and Saliva. Anal Chem 2017;89(5):2901–8.
   PubMed Web of Science ®Google Scholar
• Flohe L, Otting F. Superoxide dismutase assays. Methods Enzymol 1984;105:93–104.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121–26.
   PubMed Web of Science ®Google Scholar
• Muller F. The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging. J Am Aging Assoc 2000;23(4):227–53.
   PubMedGoogle Scholar
• Grimm A, Eckert A. Brain aging and neurodegeneration: from a mitochondrial point of view. J Neurochem 2017;143(4):418–31.
   PubMed Web of Science ®Google Scholar
• Aqul A, Liu B, Ramirez CM, Pieper AA, Estill SJ, Burns DK, et al. Unesterified cholesterol accumulation in late endosomes/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment. J Neurosci 2011;31(25):9404–13.
   PubMed Web of Science ®Google Scholar
• Macedo RC, Bondan EF, Otton R. Redox status on different regions of the central nervous system of obese and lean rats treated with green tea extract. Nutr Neurosci 2017;20: 1–13.
   PubMedGoogle Scholar
• Clement AB, Gamerdinger M, Tamboli IY, Lütjohann D, Walter J, Greeve I, et al. Adaptation of neuronal cells to chronic oxidative stress is associated with altered cholesterol and sphingolipid homeostasis and lysosomal function. J Neurochem 2009;111(3):669–82.
   PubMed Web of Science ®Google Scholar
• Austin SA, Santhanam AVR, d'Uscio LV, Katusic ZS. Regional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative Stress. PLoS One 2015;10(12):e0144062.
   PubMed Web of Science ®Google Scholar
• Mueller K, Sacher J, Arelin K, Holiga S, Kratzsch J, Villringer A, et al. Overweight and obesity are associated with neuronal injury in the human cerebellum and hippocampus in young adults: a combined MRI, serum marker and gene expression study. Transl Psychiatry 2012;2:e200.
   PubMed Web of Science ®Google Scholar
• Abidin I, Aydin-Abidin S, Bodur A, Ince I, Alver A. Brain-derived neurotropic factor (BDNF) heterozygous mice are more susceptible to synaptic protein loss in cerebral cortex during high fat diet. Arch Physiol Biochem 2017;123: 1–6.
   PubMedGoogle Scholar
• Liu Y, Zhang Q, Wang L, Wang H, Sun T, Xia H, et al. The alpha-lipoic acid improves high-fat diet-induced cerebral damage through inhibition of oxidative stress and inflammatory reaction. Environ Toxicol Pharmacol 2017;56:219–24.
   PubMed Web of Science ®Google Scholar
• Mecocci P, Boccardi V, Cecchetti R, Bastiani P, Scamosci M, Ruggiero C, et al. A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks. J Alzheimers Dis 2018;62(3):1319–35.
   PubMed Web of Science ®Google Scholar
• Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993;34(4):609–16.
   PubMed Web of Science ®Google Scholar
• Yu W, Gong JS, Ko M, Garver WS, Yanagisawa K, Michikawa M. Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J Biol Chem 2005;280(12):11731–9.
   PubMed Web of Science ®Google Scholar
• Paul R, Choudhury A, Kumar S, Giri A, Sandhir R, Borah A. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress. PLoS One 2017;12(2):e0171285.
   PubMed Web of Science ®Google Scholar
• Charman M, Kennedy BE, Osborne N, Karten B. MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein. J Lipid Res 2010;51(5):1023–34.
   PubMed Web of Science ®Google Scholar
• Balboa E, Castro J, Pinochet MJ, Cancino GI, Matías N, José Sáez P, et al. MLN64 induces mitochondrial dysfunction associated with increased mitochondrial cholesterol content. Redox Biol 2017;12:274–84.
   PubMed Web of Science ®Google Scholar